Holen Sie sich die Stockscreener-App
23.01
1.67%
-0.39
Schlusskurs vom Vortag:
$23.40
Offen:
$23.55
24-Stunden-Volumen:
308.85K
Relative Volume:
1.18
Marktkapitalisierung:
$1.56B
Einnahmen:
$-9,000
Nettoeinkommen (Verlust:
$-68.03M
KGV:
-21.91
EPS:
-1.05
Netto-Cashflow:
$-44.76M
1W Leistung:
+10.89%
1M Leistung:
+62.61%
6M Leistung:
+37.05%
1J Leistung:
+7.47%
1-Tages-Spanne:
$22.98
$24.87
1-Wochen-Bereich:
$20.33
$26.30
52-Wochen-Spanne:
$12.56
$26.30
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
23.01 | 1.59B | -9,000 | -68.03M | -44.76M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Can Pulse Biosciences Inc. sustain its profitability2025 Technical Patterns & Verified Technical Trade Signals - mfd.ru
Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.2% Following Insider Selling - MarketBeat
PLSE shares positive first-in-human nPulse cardiac catheter data - MSN
Pulse Biosciences (PLSE) to Release Earnings on Thursday - Defense World
Pulse Biosciences (NASDAQ:PLSE) Insider Kevin Patrick Danahy Sells 20,000 Shares - MarketBeat
Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.5%Here's What Happened - MarketBeat
Why Pulse Biosciences Inc. (6L8) stock could break out in 2025Trade Entry Report & High Win Rate Trade Alerts - mfd.ru
Pulse Biosciences, Inc. (PLSE) Stock Analysis: Riding a Wave of Innovation with a 7.39% Upside Potential - DirectorsTalk Interviews
Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week HighWhat's Next? - MarketBeat
Pulse Biosciences stock hits 52-week high at 22.76 USD By Investing.com - Investing.com South Africa
Pulse Biosciences (NASDAQ:PLSE) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Pulse Biosciences stock hits 52-week high at 22.76 USD - Investing.com
PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - TradingView
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine - MedTech Dive
Pulse Biosciences Highlights Strong AF Outcomes From NPulse Feasibility Study - Nasdaq
A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge - Sahm
Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily
We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance
Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis
Pulse Biosciences Heart Device Data Fuels Stock SurgePulse Biosciences (NASDAQ:PLSE) - Benzinga
Top Midday Gainers - marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Shares Gap UpHere's What Happened - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Pulse Biosciences stock rises after positive cardiac catheter study data By Investing.com - Investing.com Canada
Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardia - The National Law Review
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - MEXC
Pulse Biosciences Achieves Success in Cardiac Catheter Study - Intellectia AI
Pulse Biosciences (PLSE) Reports Promising Clinical Data from Ca - GuruFocus
Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Investing News Network
AF heart study in 150 patients reports 96% success at 1 year - Stock Titan
Maria Sainz Joins Pulse Biosciences Board of Directors - Medical Product Outsourcing
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 - The Joplin Globe
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - BioSpace
Analyst Calls: How does TELA correlate with NasdaqPortfolio Update Summary & Stock Market Timing Techniques - baoquankhu1.vn
Pulse Biosciences' nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - Investing News Network
Mizuho Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - Defense World
Mizuho Securities Initiates Coverage on Pulse Biosciences With Outperform Rating - marketscreener.com
Mizuho initiates Pulse Biosciences stock with Outperform rating, $25 target By Investing.com - Investing.com Canada
Does Pulse Biosciences Inc. have strong fundamentalsJuly 2025 Volume & Momentum Based Trading Ideas - mfd.ru
Technical Reactions to PLSE Trends in Macro Strategies - Stock Traders Daily
Gap Down: Is Pulse Biosciences Inc exposed to currency risksJuly 2025 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
Day Trade: Does Assured Guaranty Ltd outperform in volatile marketsQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 53% Upside Potential - DirectorsTalk Interviews
Aug Outlook: Is Tiziana Life Sciences Ltd likely to announce a buybackMarket Sentiment Summary & Precise Buy Zone Tips - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) & Autonomix Medical (NASDAQ:AMIX) Financial Contrast - Defense World
Jobs Data: Can Pulse Biosciences Inc sustain earnings growthRecession Risk & Weekly High Return Stock Forecasts - baoquankhu1.vn
Geopolitics Watch: Should I trade or invest in Pulse Biosciences Inc2025 Market Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
How Pulse Biosciences Inc. stock responds to policy changesValue Stock Picks & Big Gains Low Budget - Bollywood Helpline
Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring A 54% Potential Upside - DirectorsTalk Interviews
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):